Sigma Healthcare Ltd · ASX:SIG
Sigma Healthcare — H1 2025 Earnings Presentation
24 slides from Sigma Healthcare's earnings presentation, Feb 27, 2025

Slide 1: Roadshow Presentation
Roadshow Presentation Sigma Healthcare Limited ABN 15 088 417 403 For personal use only Presenters: For more information contact: Vikesh Ramsunder Gary Woodford CEO & Managing Director Head of Corporate Affairs gary.woodford@sigmahealthcare.com.au Mark Davis www.sigmahealthcare.com.au CFO

Slide 2: Key Investment Highlights
Key Investment Highlights Australia’s largest retail pharmacy franchisor1 underpinned by 20 years of consistent growth2 in Chemist Warehouse Retail Network For personal use only Merger combines proven retailing strengths with highly efficient supply chain capabilities to support ongoing network expa

Slide 3: Snapshot of the Merged Group
Snapshot of the Merged Group The Merged Group is a leading Australian retail pharmacy franchisor and a full-line pharmaceutical wholesaler and distributor For personal use only Operational highlights Financial highlights 879 81 $9.6bn +10% Australian Franchise International stores LTM Dec-24 CW LFL

Slide 4: Chemist Warehouse's Growth Track Record
Chemist Warehouse’s Growth Track Record 20 years of consecutive growth in Chemist Warehouse Retail Network For personal use only CW Retail Network Sales evolution ($m)1,2,3 CW Retail Network evolution (no. of stores)1,4 10 year avg. new 5 year avg. new 10 year CAGR: 5 year CAGR: stores p.a.: stores

Slide 5: Benefits of the Merger
Benefits of the Merger Cross-application of Chemist Warehouse marketing and media capabilities For personal use only Retail expertise Extend value-added franchise services to Amcal and DDS brand platforms Expansion of private label and exclusive brands Lower distribution costs and deepen exist

Slide 6: The Merged Group's Competitive Strengths
The Merged Group’s Competitive Strengths Complementary capabilities: combines highly efficient supply chain with 15 For personal use only proven retail expertise to deliver exceptional value and enable growth Distribution centres across ANZ1 Market leading franchise model: delivers strong outcomes

Slide 7: Complementary Franchise Brands Across Broad Market Segments
Complementary Franchise Brands Across Broad Market Segments For personal use only Big box • 527 stores in Australia2 • Significant Australian pharmacy brand with franchise pharmacies known for offering a wide discount range of FOS products, and everyday low prices on all product lines1 • 522 sqm avg

Slide 8: Differentiated Chemist Warehouse Retail Offering
Differentiated Chemist Warehouse Retail Offering Iconic and well recognised brand in Australia Extensive FOS offering For personal use only Chemist Warehouse has established itself as a highly recognisable brand amongst Chemist Warehouse stores display a breadth and range of stock not commonly consu

Slide 9: Case Study: Messi Fragrance Launch
Case Study: Messi Fragrance Launch “More than we see” Australian expertise, ingenuity and know-how trusted to deliver a global success story For personal use only ● Through its GameOn subsidiary, CWG wins a 2022/23 global pitch for the exclusive licence to develop the Messi fragrance range ● CWG int

Slide 10: Growth Pillar: Domestic Store Rollout
Growth Pillar 1 Domestic Store Rollout Current Australian Retail Network1 Growth opportunity For personal use only CW has a proven track record of sustained strong domestic growth Under penetration in certain states provides organic growth opportunities Opportunity to expand Amcal and DDS network th

Slide 11: Growth Pillar: International Store Rollout
Growth Pillar 2 International Store Rollout International Store Network1 Growth opportunity For personal use only Total # Registered CW International Store Network Pharmacies The NZ experience demonstrates the transportability and acceptance of the Chemist Warehouse brand and value proposition in ne

Slide 12: Growth Pillar: Supply Chain Capabilities Drive Scale and Efficiency
Growth Pillar 3 Supply Chain Capabilities Drive Scale and Efficiency Comprehensive DC network in Australia1 Network optimisation For personal use only 272k Optimise capacity and throughput at warehouses Aggregate capacity (sqm) of 14 DCs in Australia1 Enhance distribution efficiencies and remove dup

Slide 13: Providing Superior Outcomes for Consumers, Franchisees and Supplier Partners
Growth Pillar 4 Providing Superior Outcomes for Consumers, Franchisees and Supplier Partners Consumers For personal use only Expand range of owned, private label A and exclusive brands and products B Grow online penetration / omni-channel Greater choice Margin driver Convenience $821m 3m 16% C

Slide 14: Financial Information
Financial Information For personal use only

Slide 15: Approach to Sigma's Future Financial Reporting
Approach to Sigma’s Future Financial Reporting Accounting for the Transaction Near term future financial reporting For personal use only CWG standalone results Sigma FY25 results Legal acquiror 6 months to 31-Dec-24 12 months to 30-Jun-25 12 months of CWG financial Presented today information and Si

Slide 16: CWG Standalone 1H25 Results Highlights
CWG Standalone 1H25 Results Highlights Sustained growth through new franchise store openings, international expansion, strong Like-for-Like sales growth and new supply agreements also benefitting margins For personal use only Financial Performance 1H25 Commentary Growth vs. 1H FY25 1H FY24 Strong ea

Slide 17: CWG Standalone 1H25 Statutory Results
CWG Standalone 1H25 Statutory Results Statutory Profit & Loss – No normalisation adjustments $’000 1H FY25 1H FY24 Commentary For personal use only Total Revenue 1,963,661 1,771,244 • Financials for CWG represent statutory results before any normalisations or Gross Profit 677,302 556,007 management

Slide 18: Sigma Standalone FY25 Trading Update
Sigma Standalone FY25 Trading Update • Upgraded Sigma standalone full year normalised EBIT guidance of $64 – 70m for the year ending 31 January 2025 For personal use only — Up from $50 – 60m range previously guided in September 2024 • Upgrade driven by improved operational performance — Strong execu

Slide 19: Board & Governance
For personal use only Board & Governance

Slide 20: Board of Directors
Board of Directors For personal use only Michael Sammells Vikesh Ramsunder Dr Christopher (Chris) Roberts AO Annette Carey Neville Mitchell Independent Non-Executive Chief Executive Officer & Independent Independent Independent Chairman Managing Director Non-Executive Director Non-Executive Director

Slide 21: Related Party Governance Framework
Related Party Governance Framework For personal use only • Negotiate and enter into Future Related Party Dealings • Renew and amend Existing Related Party Arrangements Related Party and Future Related Party Dealings Independent Board • Ensure that, at all times, the Existing Related Party Committee

Slide 22: Outlook
For personal use only Outlook

Slide 23: Outlook
Outlook For personal use only • Continued momentum in Retail Network sales driven by strong customer value proposition and new store openings in both the domestic and international markets • Extract efficiencies in the distribution network through a number of initiatives, including: — Optimising inv

Slide 24: Thank you
For personal use only Thank you
Source: ASX announcement, Feb 27, 2025
More decks from Sigma Healthcare Ltd
Shareholder Meeting (October 2026)15 slides · Oct 21, 2026
FY2026 Earnings Presentation26 slides · Aug 27, 2026
H1 2026 Earnings Presentation21 slides · Feb 26, 2026
Shareholder Meeting (October 2025)13 slides · Oct 22, 2025
FY2025 Earnings Presentation27 slides · Aug 27, 2025
Macquarie Sydney Conference 202515 slides · May 6, 2025